Abstract
The bone collagen of human osteogenesis imperfecta is a potent inhibitor ofin vitro calcification. The inhibition was removed by treatment of the collagen with pyrophosphate in the presence of magnesium ions. Elevated levels of serum and urinary inorganic pyrophosphate were found in 28 patients with osteogenesis imperfecta. Oral administration of magnesium oxide or magnesium sulfate to four of these patients significantly reduced their serum and urinary levels of pyrophosphate.
Résumé
Du collagène osseux provenant de fragments d'ostéogenèse imparfaite est un puissant inhibiteur de la calcificationin vitro. Cet effet inhibiteur peut être supprimé par traitement du collagène à la pyrophosphatase en présence d'ions de magnésium. Des concentrations élevées de pyrophosphates inorganiques sérique et urinaire ont été observées chez 28 malades atteints d'ostéogenèse imparfaite. L'administration buccale d'oxyde de magnésium ou de sulfate de magnésium à quatre de ces malades diminue de façon significative la quantité des pyrophosphates sérique et urinaire.
Zusammenfassung
Der Knochenkollagen von Osteogenesis imperfecta-Kranken ist ein mächtiger Hemmstoff für die Verkalkung in vitro. Die Inhibition wird durch Behandlung des Kollagens mit Pyrophosphatase in Anwesenheit von Magnesiumionen aufgehoben. Erhöhte Spiegel von anorganischem Pyrophosphat wurden im Urin und im Serum von 28 Kranken mit Osteogenesis imperfecta gefunden. Wurden 4 Patienten mit peroralen Gaben von Magnesiumoxyd oder Magnesiumsulfat behandelt, so verminderte sich der Pyrophosphatspiegel im Serum und im Urin signifikant.
Similar content being viewed by others
References
Avioli, L. V., J. E. McDonald, andR. A. Singer: Excretion of pyrophosphate in disorders of bone metabolism. J. clin. Endocr.25, 912–915 (1965).
Bongiovani, A. M., M. M. Album, A. W. Root, andJ. W. Hope: Metabolic studies in hypophosphatasia and response to high phosphate intake. Abstr. Soc. Ped. Res. Pg. 6 (April 1967).
Chen, P. S., T. Y. Toribara, andH. Warner: Microdetermination of phosphorus. Analyt. Chem.28, 1756–1758 (1956).
Clark, I.: Effects of magnesium ions on calcium and phosphorus metabolism. Amer. J. Physiol.214, 348–356 (1968).
Fleisch, H., andS. Bisaz: Mechanisms of calcification: Inhibitory role of pyrophosphate. Nature (Lond.)195, 911 (1962a).
——: Isolation from urine of pyrophosphate, a calcification inhibitor. Amer. J. Physiol.203, 671–675 (1962b).
—, andW. F. Neuman: Mechanisms of calcification: Role of collagen, polyphosphates, and phosphatase. Amer. J. Physiol.200, 1296–1300 (1961).
—, andR. G. G. Russell, andS. Bisaz: Influence of pyrophosphate on the transformation of amorphous to crystalline calcium phosphate. Calc. Tiss. Res.2, 49–59 (1968).
Gitelman, H. J., S. Kukolj, andL. G. Welt: Inhibition of parathyroid gland activity by hypermagnesemia. Amer. J. Physiol.215, 483–485 (1968).
Horn, A., H. Bornig, andG. Thiele: Allosteric properties of the magnesium-dependent inorganic pyrophosphatase in mouse liver cytoplasm. Europ. J. Biochem.2, 243–249 (1967).
Irving, J. T., D. Schibler, andH. Fleisch: Bone formation in normal and Vit. D-treated rachitic rats during the administration of polyphosphates. Proc. Soc. exp. Biol. (N.Y.)122, 852–856 (1966).
MacIntyre, I.: The flame spectrophotometric determination of calcium in biological fluids and on isotopic analysis of the errors in the Kramer-Tisdall Procedure. Biochem. J.67, 164–172 (1957).
Neuman, W. F.: Metabolic interrelations.: Josiah Macy Jr. Foundation, 187 (1950); 205 (1951).
—, andM. W. Neuman: The chemical dynamics of bone mineral., p. 31. Chicago: Chicago University Press 1958.
Sauberlich, H. E., G. E. Bunce, C. A. Moore, andO. G. Stonington: Oral magnesium in the treatment of renal calculus formation. Amer. J. clin. Nutr.14, 240 (1964).
Siegel, B. M., I. A. Friedman, andS. O. Schwartz: Hemorrhagic disease in osteogenesis imperfecta. Amer. J. Med.22, 315–321 (1957).
Solomons, C. C.: The control of calcification in osteogenesis imperfecta. Society for Pediatric Research Abstr., p. 38 (1967).
—, andW. F. Neuman: On the mechanisms of calcification: The remineralization of dentin. J. biol. Chem.235, 2502–2506 (1960).
Author information
Authors and Affiliations
Additional information
This investigation was supported by U.S. Public Health Service Grant AM 08757-05 Division of Arthritis and Metabolic Diseases.
Rights and permissions
About this article
Cite this article
Solomons, C.C., Styner, J. Osteogenesis imperfecta: Effect of magnesium administration on pyrophosphate metabolism. Calc. Tis Res. 3, 318–326 (1969). https://doi.org/10.1007/BF02058674
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02058674